Tactile Medical projects $360M-$366M 2026 revenue as airway clearance ordering normalizes in Q4 (NASDAQ:TCMD)
· seekingalpha.com
TCMD Q2 2026 earnings call recap: raised revenue guidance to $360–$366M, lymphedema strength, AffloVest inventory reset, Medicare prior auth impact—read...
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...